Locations

Cork, Ireland Contract Manufacturing Capabilities

AbbVie’s Cork facility is situated in the south of Ireland, approximately 165 miles from Dublin. Our facility has an impressive track record of timely and cost efficient technical transfers.

Let's Talk ›

This facility features a new product introduction launch site, equipped with innovative technologies for the development of pipeline products.

Founded in 2001, this 13 acre drug contract manufacturing site houses a highly automated drug product manufacturing plant along with pilot scale production to support clinical drug production needs.

As a complement to our wider contract manufacturing capabilities around the world, our expertise in Cork includes tablets, mini-tablets and capsule formulations. The Cork facility is accredited by regulatory bodies, including the FDA and Irish Medicines Board (IMB) and it is licensed to distribute to the United States, Canada, Europe and much of the rest of the world.

AbbVie’s Cork, Ireland cGMP manufacturing expertise:

Tablet Coating
Spray Coating (Glatt)
Massing Granulation (High Shear)
Massing Granulation (Low Shear)
Spray Granulation (Fluid Bed)
Bi-Layer Tablets
Drying Granulation (Fluid Bed)
Capsules
Particle Coating
Direct Compression (Dry Blend)
Micro-tablets

Capabilities

Compliant drug development

Cork capabilities in include tablets, mini-tablets and capsule formulations. AbbVie Cork accredited by the FDA and Irish Medicines Board (IMB) and licensed to distribute to the US, Canada, EU and most of the world. It features a new product introduction launch site, equipped with innovative technologies specifically for the development of pipeline products. The Cork facility ISO 14001, ISO 18001, and ISO 50001 certified and meets FDA, ICH and EU requirements.